Combination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 570-581

  Rovenský, Jozef ^a   Švík, Karol ^a   Maťha, Vladimír ^b   Ištok, Richard ^a   Kamarád, Vojtěch ^b   Ebringer, Libor ^c   Ferenčík, Miroslav ^d   Stančíková, Mária ^a  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^b Pharmaceuticals sro   (Czech Republic)

^c Physics and Informatics   (Slovakia)

^d Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Adjuvant arthritis; Enterococcus faecium; Methotrexate; Selenium

Indexed keywords

ALBUMIN; METHOTREXATE; NITRATE; NITRITE; PROBIOTIC AGENT; SODIUM SELENITE;

ADJUVANT ARTHRITIS; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; BONE DENSITY; BONE MINERAL; COLONY FORMING UNIT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROCOCCUS FAECIUM; LEG EDEMA; MALE; MYCOBACTERIUM BUTYRICUM; NONHUMAN; RAT; SCORING SYSTEM; TREATMENT OUTCOME; X RAY;

ENTEROCOCCUS FAECIUM;

EID: 25444444713     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.101     Document Type: Conference Paper

References (36)

1. REID, G., J. JASS, et al. 2003. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 16: 658-672.
2. ISOLAURI, E., Y. SÜTAS, et al. 2001. Probiotics: effect on immunity. Am. J. Clin. Nutr. 73: 444S-450S.
3. TLASKALOVA-HOGENOVA, H., R. STEPANKOVA, et al. 2004. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett. 93: 97-107.
4. BELICOVA, A., J. KRAJCOVIC, et al. 1999. Antimutagenicity of milk fermented by Enterococcus faecium. Folia Microbiol. 44: 513-518.
5. MIKES, Z., M. FERENCIK, et al. 1995. Hypocholesterolemic and immunostimulatory effects of orally applied Enterococcus faecium M-74 in man. Folia Microbiol. 40: 639-646.
6. FERENCIK, M., Z. MIKES, et al. 2000. Immunostimulatory and other beneficial health effects of lactic acid bacteria. Bratisl. Lek. Listy 101: 51-53.
7. Rayman, M.P. 2000. The importance of selenium to human health. Lancet 356: 233-41.
8. PARNHAM, M.J., J. WINKELMANN & S. LEYCK. 1983. Macrophage, lymphocyte and chronic inflammatory responses in selenium deficient rodents. Association with decreased glutathione peroxidase activity. Int. J. Immunopharmacol. 5: 455-461.
9. PERETZ, A., V. SIDEROVA & J. NÉVE. 2001. Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo controlled trial. Scand. J. Rheumatol. 30: 208-212.
10. SARTOR, R.B. 1997. Review article: role of enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment. Pharmacol. Ther. 11: 17-32.
11. CEBRA, J.J. 1999. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69: 1046-1051.
12. EEROLA, E., T. MÖTTÖ, et al. 1994. Intestinal flora in early rheumatoid arthritis. Br. J. Rheumatol. 33: 1030-1038.
13. MALIN, M., P. VERRONEN & A. KORHONEN. 1997. Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defense mechanism. Inflammopharmacology 5: 219-236.
14. HATAKKA, K., J. MARTIO, et al. 2003. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand. J. Rheumatol. 32: 211-215.
15. PELTONEN, R., M. NENONEN, et al. 1997. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br. J. Rheumatol. 36: 64-68.
16. McDOUGALL, J., B. BRUCE, et al. 2002. Effects of a very low fat, vegan diet in subjects with rheumatoid arthritis. J. Altern. Complement Med. 8: 71-75.
17. KANO, H., T. KANEKO & S. KAMINOGAWA. 2002. Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J. Food Prot. 65: 153-160.
18. CHEN, T., P. ISOMÄKI, et al. 1999. Human cytokine responses induced by Gram-positive cell walls of normal intestinal microbiota. Clin. Exp. Immunol. 118: 261-267.
19. SIMELYTE, E., M. RIMPILÄINEN, et al. 2000. Bacterial cell wall-induced arthritis chemical composition and tissue distribution of four Lactobacillus strains. Infect. Immun. 68: 3535-3540.
20. ROVENSKY, J., K. SVIK, et al. 2002. Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilized Enterococcus faecium enriched with organic selenium. Folia Microbiol. 47: 573-578.
21. CORTAS, N.K. & N.W. WAKING. 1990. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36: 1440-1443.
22. WELLES, W.L., J. SILKWORTH, et al. 1985. Studies on the effect of low dose methotrexate in adjuvant arthritis. J. Rheumatol. 12: 904-906.
23. PARNHAM, M.J., S. LEYCK, et al. 1987. Ebselen a new approach to the inhibition of peroxide-dependent inflammation. Int. J. Tissue React. 9: 45-50.
24. CONNOLLY, K.M., V.J. STECHER, et al. 1988. Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate. Int. J. Immunopharmacol. 10: 717-728.
25. TARP, U. 1994. Selenium and selenium-dependent glutathione peroxidase in rheumatoid arthritis. Dan. Med. Bull. 41: 264-274.
26. STAMLER, J.S., D.J. SINGEL & J. LOSCALZO. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902.
27. OYANAGUI, Y. 1994. Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci. 54: PL285-PL289.
28. CANNON, G.W., S.J. OPENSHAW, et al. 1996. Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum. 39: 1677-1684.
29. STEFANOVIC-RACIC, M., K. MEYERS, et al. 1995. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J. Rheumatol. 22: 1992-1998.
30. UEKI, Y., S. MIYAKE, et al. 1996. Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23: 230-236.
31. OMATA, T., Y. SEGAWA, et al. 1997. Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis. Res. Exp. Med. 197: 81-90.
32. BONNET, J., E. ZERATH, et al. 1993. Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect. J. Bone Miner. Res. 8: 659-668.
33. SUZUKI, Y., M. NAKAGAWA, et al. 1997. Short-term low dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant-induced arthritis. J. Rheumatol. 24: 1890-1895.
34. KAWAI, S., K. NAGAI, et al. 1997. Low-dose pulse methotrexate inhibits articular destruction of adjuvant arthritis in rats. J. Pharm. Pharmacol. 49: 213-215.
35. MORGAN, S.L., J.E. BAGGOTT, et al. 2001. MTX affects inflammation and tissue destruction differently in the rat AA model. J. Rheumatol. 28: 1476-1481.
36. MAO, Y., S, NOBAEK, et al. 1996. The effect of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111: 334-344.